Cargando…

Single dose oral pharmacokinetic profile rubraxanthone in mice

Rubraxanthone is a main active constituent of kandis (Garcinia cowa Roxb), has showed many biological activity including antimicrobial, anti hypercholesterolemic, antiplatelet, antioxidant, cytotoxic, and anti-inflammatory properties. To the best of our knowledge, no reports on the pharmacokinetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Susanti, Meri, Darmianti, Riski, Harahap, Yahdiana, Itam, Afrizal, Hamidi, Dachriyanus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941156/
https://www.ncbi.nlm.nih.gov/pubmed/35342834
http://dx.doi.org/10.1016/j.heliyon.2022.e09104
_version_ 1784673049691291648
author Susanti, Meri
Darmianti, Riski
Harahap, Yahdiana
Itam, Afrizal
Hamidi, Dachriyanus
author_facet Susanti, Meri
Darmianti, Riski
Harahap, Yahdiana
Itam, Afrizal
Hamidi, Dachriyanus
author_sort Susanti, Meri
collection PubMed
description Rubraxanthone is a main active constituent of kandis (Garcinia cowa Roxb), has showed many biological activity including antimicrobial, anti hypercholesterolemic, antiplatelet, antioxidant, cytotoxic, and anti-inflammatory properties. To the best of our knowledge, no reports on the pharmacokinetics (PK) of this rubraxanthone have been published. The PK of rubraxanthone in mice was examined after a single oral dose of 700 mg/kg rubraxanthone suspension in virgin coconut oil. Plasma samples were collected at different time points and further analyzed using validated chromatographic method. Pharmacokinetic parameters were calculated from observed plasma concentration-time profile. The maximum concentration of rubraxanthone in plasma was discovered in 1.5 h. The peak plasma concentration (C(max)) was 4.267 μg/mL, and the area under the curve (AUCt0-t [Formula: see text]) was 560.99 μg h/L, with a 6.72-hour terminal half-life (T(1/2)). The volume of distribution (Vd/F) was 1200.19 mL/kg and 1123.88 mL/h/kg clearance (Cl/F).
format Online
Article
Text
id pubmed-8941156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89411562022-03-24 Single dose oral pharmacokinetic profile rubraxanthone in mice Susanti, Meri Darmianti, Riski Harahap, Yahdiana Itam, Afrizal Hamidi, Dachriyanus Heliyon Research Article Rubraxanthone is a main active constituent of kandis (Garcinia cowa Roxb), has showed many biological activity including antimicrobial, anti hypercholesterolemic, antiplatelet, antioxidant, cytotoxic, and anti-inflammatory properties. To the best of our knowledge, no reports on the pharmacokinetics (PK) of this rubraxanthone have been published. The PK of rubraxanthone in mice was examined after a single oral dose of 700 mg/kg rubraxanthone suspension in virgin coconut oil. Plasma samples were collected at different time points and further analyzed using validated chromatographic method. Pharmacokinetic parameters were calculated from observed plasma concentration-time profile. The maximum concentration of rubraxanthone in plasma was discovered in 1.5 h. The peak plasma concentration (C(max)) was 4.267 μg/mL, and the area under the curve (AUCt0-t [Formula: see text]) was 560.99 μg h/L, with a 6.72-hour terminal half-life (T(1/2)). The volume of distribution (Vd/F) was 1200.19 mL/kg and 1123.88 mL/h/kg clearance (Cl/F). Elsevier 2022-03-14 /pmc/articles/PMC8941156/ /pubmed/35342834 http://dx.doi.org/10.1016/j.heliyon.2022.e09104 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Susanti, Meri
Darmianti, Riski
Harahap, Yahdiana
Itam, Afrizal
Hamidi, Dachriyanus
Single dose oral pharmacokinetic profile rubraxanthone in mice
title Single dose oral pharmacokinetic profile rubraxanthone in mice
title_full Single dose oral pharmacokinetic profile rubraxanthone in mice
title_fullStr Single dose oral pharmacokinetic profile rubraxanthone in mice
title_full_unstemmed Single dose oral pharmacokinetic profile rubraxanthone in mice
title_short Single dose oral pharmacokinetic profile rubraxanthone in mice
title_sort single dose oral pharmacokinetic profile rubraxanthone in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941156/
https://www.ncbi.nlm.nih.gov/pubmed/35342834
http://dx.doi.org/10.1016/j.heliyon.2022.e09104
work_keys_str_mv AT susantimeri singledoseoralpharmacokineticprofilerubraxanthoneinmice
AT darmiantiriski singledoseoralpharmacokineticprofilerubraxanthoneinmice
AT harahapyahdiana singledoseoralpharmacokineticprofilerubraxanthoneinmice
AT itamafrizal singledoseoralpharmacokineticprofilerubraxanthoneinmice
AT hamididachriyanus singledoseoralpharmacokineticprofilerubraxanthoneinmice